Oncoinvent ASA: Invitation to business update Wednesday 29 April 2026

Oslo, Norway, 23 April 2026 - Oncoinvent ASA (ONCIN), a biotech company developing a receptor-independent alpha radiopharmaceutical to eradicate cancer cells in the abdominal cavity after surgery with a single, targeted dose, is pleased to invite investors, analysts, and stakeholders to a live webcast event at 8:00 AM CET on Wednesday, 29 April 2026.

Webcast: 

• Date: Wednesday, 29 April 2026
• Time: 8:00am CET
• Webcast link: click here for link 

The presentation will on the same day be made available on the Investor Relations section of the Company's website at www.oncoinvent.com. A recording of the webcast will be made available after the live sending.

Oncoinvent reports its financial results on a half-yearly basis, complemented by quarterly business updates to keep investors, analysts, and stakeholders informed and ensure ongoing transparency.